Maturation of rotavirus involves an intracellular membrane budding event in which the single-shelled icosahedral particle interacts with a virus-encoded receptor glycoprotein, NS28, that is located in the rough endoplasmic reticulum membrane. The receptor is a tetramer and is oriented with the C-terminal 131 amino acids on the cytoplasmic side of the membrane (A. R. Bellamy and G. W. Both, Adv. Virus Res. 38:1-48, 1990). We have used the T7-vaccinia virus transient expression system to deliver mutant variants of the NS28 gene to CV1 cells in order to assess the effects of site-specific modifications on receptor function. Three types of mutant proteins have been constructed by altering the extreme C-terminal methionine, cysteine residues within the third hydrophobic domain, and internal residues located within the cytoplasmic portion of the receptor, respectively. Deletion or conservative substitution of the C-terminal methionine completely abolishes receptor activity. Substitution of cysteine residues has no effect on receptor activity or on the ability of the receptor to adopt its native oligomeric state. Internal deletions result only in a reduction in the level of binding. An N-terminally truncated form of the receptor, containing only the cytoplasmic domain, retains full receptor activity and can form membrane-associated tetramers.
Rotaviruses, members of the family Reoviridae, are major etiologic agents of infantile gastroenteritis (7) . The icosahedral 70-nm-diameter infectious particle consists of a segmented double-stranded RNA genome enclosed in a doubleshelled protein capsid. In the infected cell, 55-nm-diameter subviral single-shelled particles (SSP) assemble in viroplasmic inclusion bodies adjacent to the rough endoplasmic reticulum (RER) membrane (3, 13) . In the final stages of rotavirus maturation, the SSP are transferred from the cytoplasm to the lumen of the RER, acquiring in the process an ephemeral membrane envelope (20, 21) . Proteins of the outer shell, VP4 and VP7, are assembled onto the core either during this process or once the particle reaches the lumen.
The membrane budding event is initiated by the interaction of the SSP with a virus-encoded receptor which is located in the RER membrane. The receptor is a 28-kDa nonstructural glycoprotein (NS28) encoded by genomic segment 10 (2, 19) . NS28 is a protein of 175 amino acids with three internal hydrophobic domains (HI, H2, and H3). Asparagine residues at positions 8 and 18 are glycosylated with high-mannose carbohydrate (5) , indicating that this region of the protein is localized to the RER lumen and that the protein does not reach the Golgi apparatus. The protease sensitivity of the C-terminal domain (4) indicates that it lies on the cytoplasmic side of the membrane with the second hydrophobic region (H2) acting as the transmembrane domain; this leaves the C-terminal 131 residues available to perform the receptor function of interaction with the SSP. The receptor has recently been shown to be a homotetramer (16) , and Scatchard analysis (1, 19) M. The ligand for the receptor is VP6, the major surface protein of the SSP (19) .
We now report on the functional dissection of the NS28 receptor polypeptide using a transfection system to deliver mutant forms of the receptor protein to CV1 cells. This system employs a recombinant vaccinia virus to deliver T7 DNA polymerase to cells which are subsequently transfected with a plasmid carrying engineered variants of the NS28 gene under the transcriptional control of the powerful T7 promoter (9) . The transient expression system has enabled variant forms of the protein to be evaluated for both their receptor function and the ability to form stable oligomers. We demonstrate here that only the cytoplasmic domain is necessary for correct oligomerization and receptor function and that the presence of the C-terminal methionine is a requirement for the maintenance of receptor function.
MATERIALS AND METHODS
Virus and cells. CV1 cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum. Human TK-143 cells were grown in minimum essential medium with Earle's salts with 10% fetal bovine serum and 50 ,ug of bromodeoxyuridine per ml. Cultures (400 ml) of Spodoptera frugiperda cells were grown in Sf900 medium (18) at 28°C in 21 spinner flasks. Rotavirus (strain SAl1) was propagated in MA104 cells as described previously (24) . Recombinant vaccinia virus vvTF7.3, containing the bacteriophage T7 RNA polymerase gene under the control of the 7.5K late promoter, was obtained from B. Moss (National Institutes of Health, Bethesda, Md.) and was propagated in CV1 cells. A recombinant vaccinia virus containing the NS28 gene inserted downstream from the 7.5K promoter (vvNS28) was constructed as described previously (19 Measurement of receptor activity. Mutant and wild-type NS28 proteins were assayed for receptor activity after transient expression in CV1 cells. Twenty-microliter aliquots of cell lysates were incubated at room temperature with 125I-labelled rotavirus as previously described (19) to allow the SSP to bind to the membranes. The mixture was centrifuged (3,000 x g) for 10 min, and the bound radioactivity in the pellet was measured.
SDS-polyacrylamide gel electrophoresis and Western blot (immunoblot) analysis. Cell extracts were mixed 1:1 with Laemmli loading buffer (15) and boiled for 3 min prior to electrophoresis on either 10 or 15% discontinuous polyacrylamide-sodium dodecyl sulfate (SDS) gels. Proteins were then transferred to nitrocellulose (26) , and blots were developed with a rabbit polyclonal antiserum (prepared against SAil-infected cells) and biotinylated sheep anti-rabbit immunoglobulin (Amersham) or 1251I-labelled protein A (New England Nuclear).
Cross-linking. Cross-linking was performed on either transfected cell lysates or monolayers of intact cells. For cross-linking of cell lysates, a stock solution of dithiobis (succinimidylpropionate) (Pierce) (50 mM in dimethyl sulfoxide) was added to lysates to a final concentration of 1 mM and incubated for 60 min at room temperature. The reaction was terminated by the addition of 4 mM glycine, and the membranes were pelleted by spinning for 10 min in a microcentrifuge. Samples were resuspended in Laemmli sample buffer either with or without 50 mM dithiothreitol. Cross-linking of intact-cell monolayers was performed essentially as described by Sugrue and Hay (25) . A stock solution of ethylene glycolbis (succinimidyl succinate) (Pierce) (25 mg/ml in dimethyl sulfoxide) was diluted to a final concentration of 1 mg/ml in PBS. Ten-milliliter samples of this solution were added to monolayers of CV1 cells (28 h posttransfection) which had been washed in ice-cold PBS. After an overnight incubation at 4°C, glycine was added to a final concentration of 4 mM and the cells were harvested and lysed as described above.
RESULTS
Expression of the NS28 receptor. To assess the effects of site-specific mutations within the NS28 receptor in vivo, the gene must be delivered to a suitable cell line to yield detectable levels of receptor activity. Figure 1 presents (4) indicates that the C-terminal (cytoplasmic) 131 residues are available to interact with the SSP (Fig. 2) (Fig. 3A) therefore was compared with the amount of protein detectable by Western blotting using a polyclonal antiserum prepared against SAil-infected MA104 cells (20) (Fig. 3B) . Although yields of receptor protein differed slightly, class 1 and 2 mutants (Fig. 3B, lanes 3 to 11) were To determine the effect of each mutation on receptor activity, membranes from transfected cells were assayed for their ability to bind 125I-labelled SSP in the in vitro binding assay (Fig. 3A) . Membranes from cells expressing wild-type NS28 typically gave a 10-fold excess of bound radioactivity over control samples prepared from cells transfected with pTF29 containing the NS28 gene in the reverse orientation (Fig. 3A, lanes 1 and 2) . All class 1 mutants (lanes 3 to 8) exhibited a complete loss of binding activity with the exception of mutant 176G, in which an extra glycine residue was added to the extreme C terminus but which nevertheless gave wild-type levels of binding. Thus, for class 1 mutants, a somewhat surprising result is obtained, viz., removal of as little as the terminal methionine residue is sufficient to abolish receptor activity.
For class 2 mutants (Fig. 3A, lanes 9 to 11) , the alteration of either one or both of the cysteine residues at positions 63 and 71 to serine had no major effect on receptor activity of the mutant protein. This observation implies that if inter-or intramolecular disulfide bridges occur between these residues, they are not essential for the maintenance of a "receptor-positive" structure. Class 3 mutants (lanes 12 to 16) exhibited between 60 and 80% of wild-type receptor activity. In view of their overall lower level of expression, this apparent reduction in receptor activity could be attributed to a reduced amount of receptor protein present in the cell membrane. However, when Scatchard analyses were performed (Table 2) , the Kd of group 3 mutants for SSP was significantly lower than that found for wild-type NS28.
Only the cytoplasmic domain is required for receptor activity. Amino acids 44 to 175 of NS28 are located in the cytoplasm, with a protease-sensitive loop located between residues 44 and 63 ( Fig. 2 and reference 4) . To determine whether receptor activity is solely a function restricted to the cytoplasmic domain, we constructed a further mutant (Al-53) which deletes the luminal and transmembrane portion of the protein but retains H3 and the remaining C-terminal domain. Mutant A1-53 exhibits a level of receptor activity comparable with that of the full-length protein (Fig. 3A, lane  18) . The higher level of expression of this mutant reflects the use of an expression cassette containing a 5' untranslated sequence from encephalomyocarditis virus which increases the efficiency of translational initiation of uncapped mRNAs (6) . However, dilution of membranes containing mutant Intracellular localization of class 1 NS28 mutants by immunofluorescence microscopy. Given that several families of resident transmembrane endoplasmic reticulum (ER) proteins have been shown to contain retention motifs in their cytoplasmically exposed, C-terminal tails (12) , the failure of class 1 NS28 mutants to localize to the ER could be an explanation for their loss of receptor activity. In order to verify that the loss of activity of class 1 mutants is not due to the mislocalization of the mutant proteins, immunofluorescence microscopy was performed on both wild-type NS28 and the mutant 175T (Fig. 4) . A distinct perinuclear fluorescence characteristic of RER localization was obtained for this mutant (Fig. 4B) and for all other class 1 mutants examined (data not shown). In contrast, the engineered chimeric protein HAVP6sc (which localizes to the plasma membrane) exhibited the anticipated cell surface fluorescence pattern (Fig. 4C) . Thus, mutations at the C terminus of NS28 which abolish receptor activity do not affect the subcellular localization of the protein.
Cross-linking of mutant receptor proteins. To establish whether loss or reduction of binding activity can be attributed to a loss of quaternary structure, we examined the oligomeric state of several of the mutant receptor polypeptides after cross-linking using the bifunctional reagent dithiobis. Figure 5A shows that all mutants examined form highmolecular-weight complexes in the presence of the crosslinker. Failure to obtain clear evidence for the presence of tetrameric forms of NS28 may be attributed to the variable states of glycosylation achieved in the transient system. The possibility that other proteins might be involved in oligomer formation is not favored in view of the result obtained when the truncated (nonglycosylated) form was cross-linked (Fig.  SB) . The formation of oligomers was confirmed when crosslinking was reversed by the addition of dithiothreitol to the sample. In addition to the 28-kDa monomer, smaller amounts of an apparently SDS-resistant dimeric form (56 kDa) were observed for all mutants. These results suggest that the loss of receptor activity accompanying the deletion of the extreme C-terminal amino acid does not derive from the failure of the mutant receptor protein to form an oligomeric structure. In addition, our results confirm that cysteine residues at positions 63 and 71 do not contribute to the maintenance of the quaternary structure through disulfide bonds, since mutants lacking either one or both of these residues not only retain receptor activity but also assemble into an oligomeric form in vivo.
In a further experiment, we examined whether the N-terminally truncated (and nonglycosylated) protein (A1-53) could form oligomers despite the loss of the transmembrane and luminal domains. Cross-linking was performed in vivo using the cross-linker ethylene glycolbis. Figure 5B shows that the truncated cytoplasmic domain retains the ability to form oligomers, and clear evidence for the presence of the tetrameric form was obtained. Thus, while the determinants for oligomer formation cannot be identified in the mutants studied here, they must nevertheless lie wholly within the cytoplasmic domain of NS28.
DISCUSSION
Use of the T7-vaccinia virus transient expression system to deliver a range of mutant forms of NS28 has provided further evidence that this protein acts as the intracellular receptor for SSP in the absence of any other rotavirus proteins (1, 19) . Several previous experimental observations influenced the design of mutants. In particular, Au et al. (1) reported that iodination of tyrosine residues near the C terminus of NS28 significantly reduced receptor activity and were able to demonstrate that a monoclonal antibody that did not recognize an NS28 mutant lacking the C-terminal 15 amino acids completely abolished binding of SSP. The class 1 mutants we constructed (Table 1) have the smallest deletions or substitutions which have been shown to affect receptor activity and were the result of the sequential generation of a larger series of C-terminally truncated mutants, all of which were found to lack receptor activity. Given that these mutants retain their ability to associate with the ER membrane, our results demonstrate conclusively that the structural integrity of the extreme C terminal residue is critical for receptor activity. Even the conservative replacement of the carboxy-terminal methionine with isoleucine is sufficient to abolish binding activity. In contrast, the addition of a glycine residue to the C terminus has no effect on binding. It appears that the loss of receptor activity created by minor modifications to the C terminus of the protein, cannot be attributed to a failure of the protein to form tetramers (Fig. 5) . Rather, it seems more likely that the extreme C terminal residue of NS28 forms part of a (somewhat) hydrophobic region involved in binding. Consistent with this notion is our failure, despite repeated attempts with a range of nonionic detergents, to bind solubilized NS28 receptor to the SSP. We attribute this failure to detergent micelles blocking a hydrophobic "pocket" that is involved in binding of the SSP.
It has previously been implied (16) that cysteine residues at positions 63 and 71 might contribute to the maintainance of the oligomeric structure of NS28, although cytoplasmically located proteins containing disulfide bonds are known to be rare. Our results indicate that disulfide bonds do not contribute significantly to the structure or function of the receptor in vivo. A further important finding from this work is that the truncated form of the protein that corresponds to the cytoplasmic domain (amino acids 54 to 175) retains both biological activity and the ability to form membrane-associated tetramers. Previous evidence indicates that mutants of this type retain the ability to associate with membranes, probably through retention of the third (H3) hydrophobic domain (4) .
Finally, it should be noted that there are two features of the rotavirus receptor-ligand interaction characterized here that set it apart as an attractive model for the study of processes occurring at membrane surfaces. First, the NS28 receptor is located intracellularly and is one of a relatively small group of membrane glycoproteins which are localized exclusively to the ER. Second, the interaction between the receptor and the SSP precedes a specific budding event in which the SSP is transferred across the ER membrane from the cytoplasm to the lumen. Topologically, the transfer of the SSP across the ER is equivalent to the maturation event involved in most membrane-enveloped viruses (23) where a budding event transfers an assembled viral core from the cytoplasm to the exterior of the cell. The rotavirus intracellular receptor-ligand interaction therefore provides the opportunity to investigate the events preceding budding for which cloned genes of the interacting proteins are available and where the particle involved can be crystallized (10a).
